KROPZ PLC — Capital/Financing Update 2026

Apr 30, 2026

National Storage Mechanism | Additional information

RNS Number : 6366C

Kropz PLC

30 April 2026

30 April 2026

Kropz plc

("Kropz" or the "Company")

Receipt of Exchange Control Approval,

Admission Date of New Ordinary Shares

and

Total Voting Rights

Kropz plc (AIM: KRPZ), an emerging African phosphate producer, is pleased to announce that it has received approval from the South African Reserve Bank ("Exchange Control Approval") in relation to Fundraising and Amendment to Loan Terms as announced on 25 February 2026.

Consequently, the Fundraising is now wholly unconditional.

An application has been made for the 79,776,625 new Ordinary Shares ("New Ordinary Shares") pursuant to the Fundraising to be admitted to trading on AIM ("Admission"). Dealings in respect of the New Ordinary Shares are expected to commence on or around 8.00 a.m. on 6 May 2026.

Following Admission, the Company's issued share capital will be 1,647,367,866 Ordinary Shares. This figure of 1,647,367,866 may then be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information visit www.kropz.com or contact:

Kropz Plc	Via Tavistock
Louis Loubser (CEO)	+44 (0) 207 920 3150
Grant Thornton UK LLP	Nominated Adviser
Samantha Harrison  Harrison Clarke  Ciara Donnelly	+44 (0) 20 7383 5100
Hannam & Partners	Broker
Andrew Chubb	+44 (0) 20 7907 8500
Tavistock	Financial PR & IR (UK)
Nick Elwes  Jos Simson	+44 (0) 207 920 3150  [email protected]
R&A Strategic Communications	PR (South Africa)
Charmane Russell  Marion Brower	+27 (0) 11 880 3924  [email protected]   [email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRIMMBTMTIJBBF